Literature DB >> 33270013

A Successful Treatment of Encapsulating Peritoneal Sclerosis in an Adolescent Boy on Long-term Peritoneal Dialysis: A Case Report.

Zlatan Zvizdic1, Angela Summers2, Zia Moinuddin2, David Van Dellen2, Irmina Pasic-Sefic3, Faruk Skenderi4, Semir Vranic5, Titus Augustine2.   

Abstract

Encapsulating peritoneal sclerosis (EPS) is a rare life-threatening complication associated with peritoneal dialysis (PD). EPS is characterized by progressive fibrosis and sclerosis of the peritoneum, with the formation of a membrane and tethering of loops of the small intestine resulting in intestinal obstruction. It is very rare in children. We present a case of a 16-year-old adolescent boy who developed EPS seven years after being placed on continuous ambulatory peritoneal dialysis (CAPD) complicated by several episodes of bacterial peritonitis. The diagnosis was based on clinical, radiological, intraoperative and histopathological findings. The patient was successfully treated with surgical enterolysis. During a 7-year follow-up, there have been no further episodes of small bowel obstruction documented. He still continues to be on regular hemodialysis and is awaiting a deceased donor kidney transplant. EPS is a long-term complication of peritoneal dialysis and is typically seen in adults. Rare cases may be seen in the pediatric population and require an appropriate surgical approach that is effective and lifesaving for these patients.

Entities:  

Keywords:  Encapsulating sclerosing peritonitis; Management; Peritoneal dialysis

Year:  2020        PMID: 33270013     DOI: 10.14712/23362936.2020.22

Source DB:  PubMed          Journal:  Prague Med Rep        ISSN: 1214-6994


  1 in total

Review 1.  Surgical management of Encapsulating Peritoneal Sclerosis (EPS) in children: international case series and literature review.

Authors:  Videha Sharma; Zia Moinuddin; Angela Summers; Mohan Shenoy; Nicholas Plant; Semir Vranic; Agnieszka Prytula; Zlatan Zvizdic; Vasiliki Karava; Nikoleta Printza; John Vlot; David van Dellen; Titus Augustine
Journal:  Pediatr Nephrol       Date:  2021-08-26       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.